A Dutch study involving more than 1100 men found that the antioxidant supplement Impryl did not improve fertility. The trial, ...
Many trials that measure the efficacy and safety of antidepressants for MDD exclude one third of real-world patients with the ...
Impostor participants threaten the integrity of health research, and by extension, the policies and clinical decisions built ...
Trials should assess overall survival to evaluate potential harm, with crossover limited to avoid confounding treatment ...
Millions of adults all over the world endure chronic constipation — an awkward situation marked by hard, painful, or ...
The median follow-up of 37 months showed that PSMAiSRT improved FFS and eugonadal FFS, with significant improvements in the subgroup with a PSA level of 0.3 ng/mL or more (HR, 0.17; 95% CI, 0.04-0.79; ...
A New York Times health reporter explains what makes a good study, and how she knows which papers merit an article.
Ataraxis AI, a frontier laboratory developing artificial intelligence (AI)–powered prognostic tools for oncology, and MEDSIR ...
Calcium supplements do not appear to raise dementia risk. Long-term data support their safety for older women. New findings from (ECU), Curtin University, and the University of Western Australia show ...
In the results of China Phase III clinical trial announced at the 2025 ACR, Telitacicept demonstrated statistically significant and clinically meaningful improvements in ESSDAI [EULAR (European League ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback